Hanmi Pharm CEO Gwan-Sun Lee, "We’ll promptly resume clinical trials of drug postpone in manufacturing"

Hanmi Pharm(CEO Gwan-Sun Lee) has been the Korea’s center of attention for the past 2 years. Hanmi Pharm, which has received the praise as a company to nurture the country’s future growth through a series of new drug license agreements, has experienced huge pains, such as delay of notice and issue of disclosed information leakage, within a year.

Experiencing a number of achievements and hardsh...